The IMF is hitting the road to bring you the latest myeloma research news from this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO), which begins Friday in Chicago. The meeting will draw more than 30,000 oncology professionals from all over the world. IMF board member and myeloma patient Mike Katz, who has conducted video interviews with researchers for nearly 10 years at ASCO and ASH (American Society of Hematology), shares his thoughts on how far the IMF has come in reporting from medical meetings in the 10 years since he began and what news he’s looking forward to this year.
Q. How have things changed during the decade the IMF has been reporting from major medical meetings such as ASCO?
A. The technology has gotten so much better. HD video and quality audio equipment is now super compact and inexpensive. We used to drag lots of heavy equipment and get cheesy recordings. Now, we can bring a professional studio in our briefcases and capture really nice video.
The scientists have gotten into the routine of presenting their results for the webcast and are much more comfortable. Video streaming has become more accessible for the myeloma community with the ubiquity of broadband connections. So we get better quality videos with more articulate and comfortable presenters, viewed by a growing audience in the myeloma community.
Q. What are you excited to hear about at ASCO 2013?
A. New agents at various stages of development and work on new combinations that are bringing response rates to new highs for both newly diagnosed myeloma patients and relapsed refractory patients.
Stay tuned for video interviews from ASCO 2013.